Daily Digest

2025-12-18

168 filings captured.

Back to index

Overview

Weight Maintenance Success: Eli Lilly’s Orhorgilpron (oral GLP-1 receptor agonist) showed significant weight maintenance in ATTAIN-MAINTAIN phase 3 trial, achieving primary and all key secondary endpoints.
Obesity Treatment Approval Pending: Eli Lilly has submitted an application for FDA approval of Orhorgilpron as a treatment for obesity.
Clinical Trial Completed: MediSinoVA completed patient enrollment for their Phase II clinical trial evaluating the safety and efficacy of MSB0012168 in patients with moderate to severe plaque psoriasis.
Stock Acquisition: AnyMind Group acquired all stocks of San Smile Inc., aiming to create a global beauty economy by connecting social, e-commerce, and offline retail.
Financial Transition: G-SecondSite transitioned to consolidated financials due to acquisition, forecasting ¥1,420 million in sales and ¥160 million in operating income for the period Jan-Dec 2025.

Other

経口GLP-1受容体作動薬オルホルグリプロンに関するEli Lilly社の発表について

中外薬 (45190)

Other 20251218 22:00

Eli Lilly announced top-line results for Orhorgilpron (oral GLP-1 receptor agonist) in ATTAIN-MAINTAIN phase 3 trial.
Orhorgilpron showed significant weight maintenance compared to placebo, achieving primary and all key secondary endpoints.
Patients switching from semaglutide or ozempic to Orhorgilpron maintained their previous weight loss with an average change of -0.9 kg.
Eli Lilly has submitted an application for FDA approval of Orhorgilpron as a treatment for obesity.

ストック・オプションの募集事項の決定に関するお知らせ

Ｇ－日本スキー (60400)

Other 20251218 19:30

Purpose: Issue stock options to non-executive directors and employees to boost morale, enhance performance, and increase corporate value.
Details of Options:
Total options: 1,700 (1,400 for directors, 300 for employees)
Underlying shares: 170,000 ordinary shares
Option exercise period: December 25, 2027 to October 31, 2034
No option exercise fee
Adjustment Provisions:
Adjust for stock splits/consolidations, mergers, spinoffs, or other corporate actions.
Limit adjustments based on reasonableness and fairness.
Option Vesting and Exercise Conditions:
Hold a management position in the company or its affiliates at exercise time.
Meet certain performance targets.
Do not engage in fraudulent activities or violate laws/rules.

和泰汽車有限公司及び愛知日野自動車株式会社への経営権移管に伴う連結子会社の異動並びに特別利益（関係会社株式売却益）の計上に関するお知らせ

日野自 (72050)

Other 20251218 19:00

Subsidiary Sales:
Toyota Auto Body Co., Ltd. (Auto body business)
Daihatsu Kogyo Co., Ltd. (Auto parts business)
Nikko Engineering Co., Ltd. (Engineering business)
Financial Highlights of Sold Subsidiaries (FY20XX):
Toyota Auto Body: Revenue ~350B JPY, Operating Income ~38B JPY
Daihatsu Kogyo: Revenue ~160B JPY, Operating Income ~5B JPY
Nikko Engineering: Revenue ~170B JPY, Operating Income ~5B JPY
Potential Sale of Nippon Oil Corporation Shares
Sale Method: Tender offer or public offering, depending on market conditions
Target Completion Date: March 20XX

募集新株予約権（有償ストック・オプション)の発行に関するお知らせ

Ｇ－ベストワンドット (65770)

Other 20251218 18:15

Issued 50,000 NSSRs (March 1st - May 31st)
Subscription Price: ¥6,000 per share, Payable in Full
Lottery System for Oversubscription (100,000 shares available)
New Shares Entitle Holders to Same Rights as Existing Shareholders
No Transfer of NSSRs, Inheritance upon Death

非上場の親会社等の決算情報に関するお知らせ

Ｇ－イメージ情 (38030)

Other 20251218 18:00

Parent Company Details:
Name: Image Planning Inc.
Location: Tokyo, Japan
Representative: Reiko Code (Representative Director)
Business: Real Estate Rental
Shareholder Information as of September 30, 2025:
Total shares issued: 400
Major shareholders:
Tasuke Code (200 shares, 50%)
Reiko Code (100 shares, 25%)
Kouhei Code (100 shares, 25%)
Financial Statements for Image Planning Inc. as of September 30, 2025:
Total assets: ¥56,999,010
Total liabilities & equity: ¥56,999,010
Net income for the year ended September 30, 2025: ¥629,989

金利スワップ契約締結に関するお知らせ

Ｒ－コンフォリア (32820)

Other 20251218 18:00

Gold Swap Contract Signed: Conforia Residential Investment Trust (Conforia REIT) signed a gold swap contract on December 18, 2025.
Contract Details: The contract is for a long-term loan with a principal amount of 1,200 million yen, a 7-year term, and variable interest rate. It was executed with the Japan Securities Clearing Corporation (JSCC) and two banks: Mizuho Bank and Fujisaki Bank.
Contract Effect: The contract effectively fixes the interest rate of the long-term loan at 2.176% for 7 years.
Purpose of Contract: The purpose is to hedge against variable interest rate risk on a planned long-term loan (1,200 million yen) starting December 22, 2025.
No Change in Risk Disclosure: There are no changes to the risk disclosures regarding this gold swap contract, which were previously detailed in a securities report submitted on October 27, 2025.

取締役の担当職務の変更に関するお知らせ

野崎印 (79190)

Other 20251218 17:55

Representative Director, Yozo Nakamura, announced change in director’s role.
Hitoshi Niitani remains as managing director of the board.
Masayuki Kobayashi to continue as director and head of sales department.
Change involves role shift for Koichi Kimura from Head of Kinki-Chubu Regional Division to Head of Sales Department.
Effective date: January 5, 2026.

ＥＴＦの収益分配のお知らせ

ｉＳ米債カバコ (453A0)

Other 20251218 17:45

ETF dividend distribution for iＳ S&P 500 PLUS Index ETF (452A) set at 229 yen per unit.
ETF dividend distribution for iＳ US Treasury Bond 20+ Years Index ETF (453A) set at 46 yen per unit.
Distribution period: November 10, 2025 to December 18, 2025.
Payment date scheduled for January 26, 2026.

ＥＴＦの収益分配のお知らせ

ｉＳＳＰカバコ (452A0)

Other 20251218 17:45

ISSP Kabako (452A0) announces distribution for ETFs.
Distribution period: November 10, 2025 to December 18, 2025.
S&P 500 Equity Index ETF (452A): ¥229 per 10 units.
US Treasury Bond 20+ Year Index ETF (453A): ¥46 per 10 units.
Distribution payment date: January 26, 2026.

短期資金の借入及びコミットメントライン契約の締結に関するお知らせ

Ｇ－Ａｉロボティクス (247A0)

Other 20251218 17:30

Purpose: Secure flexible and stable funding for high growth and strengthen financial base.
Short-term Loan:
Lenders: Sumitomo Mitsui Banking Corporation, Mizuho Bank
Amount: ¥15 billion
Maturity: March 19, 2026
Interest: Prime + spread
No collateral or guarantee
Usage: Working capital
Commitment Line:
Lender: Mizuho Bank
Commitment Amount: ¥20 billion
Effective Date: December 24, 2025
Expiration: December 24, 2026
Drawdown Plan: December 26, 2025
Interest: Prime + spread
No collateral or guarantee
Usage: Working capital

第三者割当による行使価額修正条項付第10回新株予約権及び第11回新株予約権の不行使期間指定に関するお知らせ

ＷＳＣＯＰＥ (66190)

Other 20251218 17:30

WScope (66190) modifies exercisable period for 10th and 11th share subscription rights
Modification due to insufficient fund raising caused by low stock price
10th share subscription right: Un exercisable from Dec 25, 2025 to Jan 13, 2026 (10 trading days), affecting 15,999 rights
11th share subscription right: Un exercisable from Dec 25, 2025 to Jan 13, 2026 (10 trading days), affecting 10,000 rights

サン・スマイル社のグループ参画について

Ｇ－ＡｎｙＭｉｎｄ (50270)

Other 20251218 17:30

Acquisition of San Smile Inc: AnyMind Group is acquiring all stocks of San Smile Inc, a company specializing in beauty and cosmetics products.
Strategic Alignment: The acquisition aligns with AnyMind’s strategy to create a global beauty economy by connecting social, e-commerce, and offline retail.
Cross-Brand Support: After the acquisition, AnyMind will support San Smile’s brands across social media marketing, e-commerce, and offline sales.
Mergers & Acquisitions Track Record: AnyMind has successfully grown through previous acquisitions in Indonesia, Malaysia, and Japan.
Disclaimer: The document is informational only and not a solicitation for securities. AnyMind does not guarantee the accuracy or completeness of information provided.

連結決算への移行に伴う連結業績予想の公表に関するお知らせ

Ｇ－セカンドサイト (50280)

Other 20251218 17:30

Transition to consolidated financials due to acquisition of Break’s Inc.
Consolidated sales forecast: ¥1,420 million for the period Jan-Dec 2025.
Consolidated operating income forecast: ¥160 million for the same period.
Only consolidated forecasts will be disclosed moving forward.

役員選任および役付取締役選定に関するお知らせ

アドバンスクリエイト (87980)

Other 20251218 17:15

Board Appointments: Hamada Yasushi, Murakami Hirohiko, Tasaka Takashi, Sakurai Yoichi, Ogasawara Naoki, Shimatani Asako, Sugiyama Atsuo, Nakamura Yasunori, and Nagao Jun have been appointed as directors.
Auditors Appointed: Ashida Hiroshi, Yanagisawa Jun, and Fukuda Taiki have been appointed as auditors.
President & CEO: Hamada Yasushi has been appointed as the President and CEO.
Board Structure: The board consists of the President & CEO, directors responsible for various departments, and both internal and external auditors.

任意の指名・報酬委員会の委員選定に関するお知らせ

アドバンスクリエイト (87980)

Other 20251218 17:15

AdvanscCreate (TSE: 8798) announces selection of “Nominating and Compensation Committee” members.
The committee, advisory to the Board, aims to enhance independence, objectivity, and explainability in director nomination and compensation processes.
It consists of 5 members: 3 independent outside directors, 1 outside director, and 1 inside director, with a majority being independent.
The chairperson is Mr. Sakurai Yoichi, an independent outside director, appointed for committee composition independence.
Committee term starts from December 18, 2025, and ends at the conclusion of the final annual general meeting of the current fiscal year.

ストックオプション（新株予約権）の割当に関するお知らせ

東京一番フーズ (30670)

Other 20251218 17:10

NSAR Allotment (Dec 23, 2024):
3,440 NSARs: 1,800 to directors, 1,615 to employees, 25 to external cooperators
NSAR Terms:
Free of charge; exercise within 7 years of allotment
Exercise price based on 5-day stock average
Shareholder approval required for transfer
Special Provisions:
NSAR adjustments during M&As, share dividends, or stock splits
NSAR Expiration: Expires if not exercised within 7 years

3D Investment Partners Pte. Ltd.からの当社のM&A戦略に関する追加書簡の受領及びそれに対する回答書の提出に関するお知らせ

東北新社 (23290)

Other 20251218 17:00

Received Additional Letter from 3D Investment Partners on M&A Strategy
Submitted Response to the Additional Letter on December 17, 2025
3DIP Requests Details in Board Meeting Minutes for Opposing Views
Company Acknowledges Importance of Due Diligence and Decision-making Process
Company Confirms Compliance with Laws and Internal Regulations for M&A Decisions

尋常性乾癬を対象としたザソシチニブ1日1回経口投与で皮膚病変の改善をもたらし治療の新時代を切り開く可能性を示した画期的な第3相臨床試験データ

武田薬 (45020)

Other 20251218 17:00

Phase 3 trial: TAK-091 (ulcerative colitis) & TAK-279 (psoriasis) demonstrated efficacy
Primary endpoints met: clinical remission, endoscopic improvement, skin lesion improvement
Safety profiles consistent with previous studies
Potential new era for psoriasis treatment indicated
No material changes to forward-looking information or past performance statements

2025年10月期　決算説明資料(スクリプト付)

のむら産業 (71310)

Other 20251218 17:00

Financial Performance (FY2025):
Net Revenue: ¥497.6B (+10.2% YoY)
Operating Income: ¥282.7B (+13.5% YoY)
Net Income Attributable to Shareholders: ¥167.9B (+16.3% YoY)
Segment Performance (YoY changes):
Packaging Business: Net sales +9.4%, Operating Income +43.4%
Logistics Packaging Business: Net sales +3.6%, Operating Income +136.7%
Future Initiatives:
New factory construction planned for Q3 FY2026
Expansion of existing Japanese factory, completion expected by end of FY2025

大口受注に関するお知らせ

ナガオカ (62390)

Other 20251218 17:00

Nagoka (62390) received a large order from Screen Internal.
The order is for a propylene plant equipment update in the Middle East, utilizing Nagoka’s previously delivered products.
Order details: Screen Internal, approximately ¥6 billion, delivery by December 2026.
This order was already included in Nagoka’s June 2025 consolidated earnings forecast and will not impact their June 2026 projections.

剰余金の配当に関するお知らせ

Ｐ－大友ロジスティク (91490)

Other 20251218 17:00

Dividend Decision: Company to distribute excess funds on 2025-10-31, with details pending.
Previous Dividend: Last dividend of ¥5 per share was paid in Dec 2024 for the 2024 Oct period.
Upcoming Shareholder Meeting: The decision will be presented at the 63rd Annual General Meeting on Jan 29, 2026.
Policy: Company prioritizes stable dividends and maintains a balance between payouts and financial strength.
No Interim Dividend: Only annual dividend of ¥5 per share is distributed.

本社移転に関するお知らせ

Ｇ－ＢＲＵＮＯ (31400)

Other 20251218 17:00

Headquarters Relocation: G-BRUNO (31400) decided to relocate its headquarters.
New Location: Shinjuku-ku, Nishi-Shinjuku, 6-chome, 22-1, Shinjuku Square Tower B1 floor (previously: Shinjuku-ku, Nishi-Shinjuku, 8-chome, 17-1, Sumitomo Fudousan Shinjuku Grand Tower 36 floor)
Relocation Date: January 1, 2026
Reason for Relocation: Consolidation of two previously separate offices (formerly in Shibaura and Minato) to improve communication, decision-making, and business efficiency.
Impact on Performance: The relocation is expected to have a negligible impact on G-BRUNO’s performance for the fiscal year ending June 2026.

当社取締役会の実効性に関する評価結果の概要について

インソース (62000)

Other 20251218 17:00

Purpose of Assessment: Enhance board effectiveness and increase corporate value.
Target Respondents: All directors (including external) and auditors (including external), totaling 12 individuals.
Highly Evaluated Areas:
Protection of shareholder rights and equality, and appropriate collaboration with other stakeholders.
Fulfillment of roles and responsibilities by the board.
Transparent disclosure of valuable information, including non-financial data like monthly KPIs.
Areas for Improvement: More thorough discussion on crucial themes such as strategy, governance, and risk management. Enhanced response to sustainability issues.

執行役員の選任および人事異動、並びに執行役員の辞任に関するお知らせ

インソース (62000)

Other 20251218 17:00

New Appointments:
Newo Takako (1987/07/16) appointed as Executive Officer, Group Business Management Division Head.
Masato Aida (1987/10/25) appointed as Executive Officer, Kansai Business Headquarters Osaka Branch Manager.
Ryozo Sasaki (1989/08/23) appointed as Executive Officer, Global Research and Development Department Marketing Division Manager.
Organizational Changes:
Kazuya Kanai moves from Executive Officer to Representative Director.
Hiroshi Kaieda resigns as Executive Officer, Global Business Promotion Room Head.
Resignation:
Konosuke Imaki resigns as Executive Officer, Global HR Department and Talent Development Division Head on December 31, 2025 due to personal reasons.

資金の借入れに関するお知らせ

Ｒ－平和ＲＥ (89660)

Other 20251218 17:00

Peace Real Estate Investment Trust (89660) announces new loans.
Loans total 5,170 million yen for partial funding of recently acquired properties (HF下赤塚レジデンス, HFときわ台レジデンス, HF綾瀬レジデンス).
New loans to be executed on Dec 23, 2025 with various banks and terms ranging from 8 to 9 years.
No collateral required for any of the loans.

連結子会社からの配当金受領に関するお知らせ

ＭＣＪ (66700)

Other 20251218 17:00

MCJ received €15 million dividend from subsidiary iiyama Benelux B.V. on Dec 18, 2025.
Dividend value in JPY: ¥2,740 million (using exchange rate of 1 EUR = 182.69 JPY).
MCJ will record this dividend as revenue in its individual financial statements for the fiscal year ending Mar 31, 2026.
Dividend receipt does not impact MCJ’s consolidated results for the same period.

AMLを対象としたmonzosertib開発推進に向けたMOUを締結

Ｇ－カルナバイオ (45720)

Other 20251218 17:00

G-CarnaBio (45720) signed a MOU with MD Anderson Cancer Center to collaborate on a physician-led trial evaluating the combination of monzosertib, azacitidine, and venetoclax for relapsed or refractory AML.
Monzosertib is an orally available, potent, and selective CDC7 kinase inhibitor developed by G-CarnaBio, currently in Phase 1 clinical trials in Japan for advanced solid tumors.
G-CarnaBio will provide the trial drug (monzosertib), safety information, and technical support for the trial, with Dr. Abhishek Maiti of MD Anderson serving as the principal investigator.
The companies aim to submit an IND application in the U.S. by mid-2026 and do not expect this collaboration to impact G-CarnaBio’s consolidated earnings forecast for the fiscal year ending December 31, 2025.
Monzosertib is a drug candidate targeting CDC7 kinase, which plays a crucial role in controlling chromosome replication during the cell cycle. It is expected to have minimal side effects and potential applications in various types of cancer where CDC7 is overexpressed.

株式の立会外分売実施に関するお知らせ

エコム (62250)

Other 20251218 16:30

Eco Corporation (6225) to conduct over-the-counter block trade on Dec 19, 2025.
30,000 shares to be sold at ¥1,766 per share.
Purchase limit per customer: 500 shares (trade unit: 100 shares).
Trade venue: Nagoya Stock Exchange.
Aim of trade: Improve stock distribution and liquidity.

ホテル運営事業における基本合意書締結のお知らせ

ロイヤルホテル (97130)

Other 20251218 16:30

Royal Hotel (97130) announces signing a basic agreement to operate a condominium hotel in Okinawa.
The hotel is planned to be built by Keihan Electric Railway Realty Co. and Sekisui House Tokai Co., Ltd.
The contract period starts from the signing of the lease reservation contract until 20 years later.
The rental fee will be determined based on the hotel’s performance, making precise prediction difficult.
The planned opening is in late 2028, with no impact on the 2026 fiscal year’s consolidated earnings.

第三者割当増資の結果に関するお知らせ

Ｇ－ククレブ (276A0)

Other 20251218 16:15

Third-party share allocation increase: Company decided on new share issuance through public subscription and third-party allotment to specific entities.
Applicant withdrawal: One applicant (Mizuho Securities) withdrew their application for the full amount of intended shares.
Cancelled issue: Due to lack of applicants, 93,600 shares will not be issued.
No investment solicitation: This disclosure is not an offer to invest; investors should review company documents before deciding.
U.S. securities law compliance: The company will not engage in securities offerings or sales in the U.S., except as registered under U.S. Securities Act of 1933.

サステナビリティ・リンク・ローンの設定目標達成による適用利率引下げのお知らせ

Ｒ－オリックスＦ (89540)

Other 20251218 16:00

Loan Rate Reduction: Applicable interest rates have been adjusted for certain sustainability-linked loans as follows:
Orix Real Estate Investment Trust (8954) reduced the applicable interest rate from 1.060% to 1.050% on a ¥2,000 million loan from Mitsubishi UFJ Bank.
The applicable interest rate for a ¥1,000 million loan from Sumitomo Mitsui Trust Bank has been reduced from 1.076% to 1.066%.
SPT Achievement: The Sustainable Performance Target (SPT) for reducing CO2 emissions by more than 26.0% compared to the baseline year (2021) was achieved in the fiscal year 2024.
Future SPT Updates: Future SPT achievements and applicable interest rates will be disclosed on Orix J-REIT’s Sustainability homepage (https://www.orixjreit.com/ja/feature/document/#sustainable-finance).
Reference Materials: For detailed information, refer to previously published notices regarding “Fundraising for Loan” (including sustainability-linked loans) dated September 14, 2023; March 15, 2024; June 14, 2024; and September 17, 2024.

代表取締役の異動に関するお知らせ

スターシーズ (30830)

Other 20251218 16:00

Change in Representative Director: Starrish Co., Ltd. (3083) has decided the following changes to its representative director.
Reason for Change:泉信彦, former Representative Director and Chairman, resigned due to completion of company’s transition to a holding company structure and achieving black numbers this fiscal year.
New Position:泉信彦 will become an Advisor (相談役) from December 18, 2025.
Effective Date: The change is effective as of December 18, 2025.

剰余金の配当に関するお知らせ

ジェイ・エス・ビー (34800)

Other 20251218 16:00

Dividend Announcement: JSB Corporation has decided to distribute excess funds on December 18, 2025.
Dividend Details (FY ended Oct 31, 2025): Ordinary dividend per share is 105 yen, totaling 2.221 billion yen.
Effective Date: The dividend becomes effective on January 28, 2026.
Dividend Source: The dividend is sourced from profit and surplus reserves.
Dividend Policy Update: JSB aims to maintain stable dividends and increase the payout ratio to 40%.

執行役員制度の変更および執行役員の人事異動に関するお知らせ

Ｇ－ＣＣＴ (43710)

Other 20251218 16:00

Role Change: “Senior Executive Officer” role abolished.
Contract Change: Executives to sign contracts with the company.
New Roles (2026 Jan 1):
Tsunoda, Sho: Executive Officer, Construction DX Business.
Hanabata, Masaki: Executive Officer, Human Resource Acquisition Support.
Kato, Jun: Executive Officer, SI Business.
Ishii, Takashi (Retiring): Formerly Senior Executive Officer, COO & Enterprise SI Business.
Morita, Atsushi (Retiring): Formerly Executive Officer, CIO & Information Systems.
New Role for Meadowa, Yoshihisa: Executive Officer, Management Planning.

欧州における次世代止血材（TDM-623）の製造販売承認取得のお知らせ

Ｇ－３Ｄマトリックス (77770)

Other 20251218 16:00

3D Matrix Europe SAS received manufacturing and sales approval for TDM-623 in Europe
TDM-623 is the first blood coagulant product by the company approved for use in neurosurgery
It has obtained approval for various applications, including neurosurgery, digestive system, cardiovascular, and solid organ surgeries
TDM-623 forms a harder gel faster than TDM-621 (PureStat) and doesn’t expand after application, reducing the risk of pressure on surrounding nerves
The company plans to begin premarketing activities in early 2026 and will conduct post-market surveillance studies

フィリピン共和国に本拠を置く企業の株式取得に関するお知らせ

理想科学 (64130)

Other 20251218 16:00

RISO KASHIKO (64130) decided to partially acquire shares of companies based in the Philippines.
The acquisition is part of a business succession plan involving Copylandia Office Systems Corporation, its successors RISO Copylandia Philippines Corp. (RCP), and Copylandia Sales Corp. (CSC).
After the succession, RISO KASHIKO will acquire partial shares in both RCP (51% ownership) and CSC (39% ownership).
The acquisition aims to expand business operations in the Philippine market.
The share transfer is expected to occur between April and May 2026.

コミットメントライン契約に基づく借入の実施について

若築建 (18880)

Other 20251218 16:00

Purpose: ISC announced a loan agreement to efficiently manage its operating funds.
Loan Details:
Implementation date: Dec 24, 2025
Lenders: 10 banks (trust banks, city banks, regional banks)
Amount and terms:
Total commitment line: ¥13 billion
Existing loan repayment: ¥9 billion
New loan amount: ¥13 billion
Maturity date: Jan 9, 2026
No collateral required
Financial Covenants:
Maintain minimum net assets of 75% compared to the highest value in the past two fiscal years.
Avoid consecutive annual operating losses.

国内不動産信託受益権の取得に関するお知らせ＜三井ショッピングパークららぽーと和泉（準共有持分71.5％）：追加取得他計3物件＞

Ｒ－フロンティア (89640)

Other 20251218 16:00

Real Estate Acquisitions:
Three Islands Shopping Park (71.5% stake) in Osaka for ¥24B.
M Building on Route 58 (100% stake) in Fukuoka for ¥1.7B.
Investment Rationale: Stable rental income and long-term capital appreciation through professional asset management.
Financing: 60% debt, 40% equity.
Risk Management: Diversification, regular review, adequate liquidity.
Exit Strategy: Not mentioned.
Portfolio Changes:
Acquiring ‘Three Shopping Parks’ in Osaka and Fukuoka for ¥36.9B.
Additional 0.9% stake in Ikebukuro Square.
71.5% undivided interest in Mitsui Shopping Park Rinku Tokyo for ¥38.042B.
Portfolio Composition After Upcoming Acquisitions:
Retail Facilities: 32 facilities (80.7%), Office Building: 1 facility (0.8%), Residential Complexes: 3 facilities (2.5%), Shopping Parks: 9 facilities (23.6%).
Total Assets: ¥439,485 million / 100%.

株式会社TBMとの資本提携を目的とした第三者割当により発行される株式の募集に関するお知らせ

Ｇ－リグア (70900)

Other 20251218 16:00

Share Issue Details: 70900 plans to issue new shares worth ~46 billion yen to TBM, aiming for a capital and business alliance.
Impact on Shareholders: Post-TPA, Hiroshi Kawase (current largest shareholder) will own ~29.25% of shares; TBM becomes significant shareholder with ~6.20%.
Financial Expectations: Minimal impact in FY2026 Q1, but anticipates long-term value enhancement through the alliance.
Subscription Details: Third-party allotment to TBM begins Dec 29, 2025, ends Jan 12, 2026; Subscription price set at ¥30 per share.

福岡証券取引所 Fukuoka PRO Market 上場承認（重複上場）のお知らせ

Ｐ－樋口総合研究所 (374A0)

Other 20251218 16:00

Company: Higuchi Sōgō Kenkyūjo (374A0)
Approved for listing on Fukuoka PRO Market (duplicate listing with Tokyo PRO Market)
Listing purpose: Enhance corporate value, governance, IR activities; tap into growing Kyushu region’s talent pool
Listing date: December 26, 2025 (planned)

グループ組織再編（子会社の現物配当による孫会社の異動）に関するお知らせ

富士ユナイトＨＤ (416A0)

Other 20251218 16:00

Fuji Unitech Holdings (416A0) announces a group organizational restructuring.
Fuji Excelsior, a wholly-owned subsidiary, will distribute its shares in three subsidiaries to Fuji Unitech via a stock dividend.
The purpose is to consolidate these companies under Fuji Unitech for better group-wide decision-making and value enhancement.
The stocks to be distributed are: Environment Development Industry (86,000 shares), Fuji Home Energy (600 shares), and Fuji Rental (28,420 shares).
The effective date of the stock dividend is January 1, 2026.

株式の売り出しに関するお知らせ

田谷 (46790)

Other 20251218 16:00

Share Offering Announcement: The company, TANAI (46790), has decided to sell 600,000 shares at ¥300 each, totaling ¥180 million.
Seller and Buyer: The seller is ‘Yugen Gaisha Teez’, owned by the president of TANAI and his family. The buyer is ‘Kabushiki Gaisha Running’.
Purpose: The sale aims to meet the Tokyo Stock Exchange’s (TSE) listing requirements, particularly the market capitalization threshold of ¥10 billion.
Effect on Shareholders: Post-sale, Teez will hold 17.27% and Running will hold 9.62% of total shares.
Timing and Process: The sale is scheduled for January 7, 2026, with applications accepted until December 18, 2025. The shares will be transferred via a private agreement between Teez and Running.

当社株式の上場廃止に関するお知らせ

日本調剤 (33410)

Other 20251218 16:00

Delisting Announcement: Nippon Chouzai (33410) ordinary shares will be delisted from the Tokyo Stock Exchange (TSE) Prime Market on December 19, 2025.
Reason for Delisting: Share consolidation approved at the extraordinary general meeting held on November 18, 2025, meets the delisting criteria set by TSE’s listing regulations.
Previous Announcement: Detailed information can be found in Nippon Chouzai’s press release dated November 18, 2025, titled “Approval of Share Consolidation and Other Related Matters”.
Gratitude and Future Commitment: The company expresses deep gratitude for the understanding and support shown by shareholders and stakeholders over the years, and commits to enhancing corporate value and contributing to society.

４社間業務提携に関するお知らせ

オリチエン工業 (63800)

Other 20251218 16:00

Purpose of Business Alliance: To improve competitiveness and survive market challenges by optimizing resources among mid-sized roller chain manufacturers.
Key Contents of the Alliance:
Complementary product supply and enlarged product lineup through mutual cooperation.
Improved production efficiency via mutual production outsourcing.
Cost reduction through centralized procurement of raw materials and components.
Technological advancement through active knowledge exchange and collaboration.
Expansion of overseas operations using each other’s international bases.
Streamlined logistics using combined distribution networks.
Alliance Partners: Kanawachi Chain Co., Ltd. (KAN), RK Japan Corporation (RK), and Kagaya Industries, Inc. (KC).
Expected Impact on Oriental Chen Industry Group’s Consolidated Results for the fiscal year ending March 2026: Minimal impact in the short term but potential long-term growth and enhanced competitiveness.

投資有価証券売却益（特別利益）の計上見込みに関するお知らせ

ジャパンクラフトＨＤ (71350)

Other 20251218 16:00

Purpose of Investment Securities Sale: Policy-driven reduction in held shares to enhance asset efficiency and strengthen financial health.
Securities Being Sold: Six listed securities held by the company’s consolidated subsidiary.
Expected Sale Completion Date: End of December 2025.
Anticipated Investment Securities Sale Benefit (as of now): Approximately 43 million yen, subject to change based on market fluctuations.
Planned Accounting for Benefit: To be recorded as extraordinary income in the second half of Q2 FY2026.

有料老人ホーム事業の一部譲渡に関するお知らせ

ビケンテクノ (97910)

Other 20251218 16:00

Biken Technos (97910) announces partial sale of its paid elder care home business.
The “Merci Masumi” facility in Takatsuki City, Osaka, is the target for sale to Charm Care Corporation (6062).
The transaction is subject to local government approval and may not proceed if talks fail.
Sale price is confidential; payment will be in cash upon completion.
The sale will have a minor impact on Biken Technos’ 2026 March quarter results.

2026年6月期の運用状況の予想の修正に関するお知らせ

Ｒ－フロンティア (89640)

Other 20251218 16:00

Revised 2026 FY Operating Forecast
Revenue: +5.7% to ¥12,354 million
Operating Profit: +5.7% to ¥6,605 million
EBITDA: +3.7% to ¥5,925 million
Net Income: +3.7% to ¥5,924 million
Dividend per Unit: Increased to ¥2,190 (including ¥26 million pressure stock redemption)
Reason for Forecast Change: Acquisition of new assets, including “Larapo Tokyo Bay Ando” and 3 other properties

金利スワップ契約の締結に関するお知らせ

Ｒ－ユナイテド (89600)

Other 20251218 16:00

United Urban Investment Trust (89600) entered a gold swap contract on Dec 18, 2025.
The purpose was to hedge interest rate risk for a term loan of 50 billion yen due on Dec 22, 2025.
The fixed rate of the swap is 1.561%, with variable receipt based on TONA (daily cumulative compound rate).
Contract runs from Dec 22, 2025 to Dec 20, 2032, with quarterly payments starting Mar 23, 2026.
Effectively fixes the term loan’s interest rate at 1.911%.

第三者割当により発行された第13回新株予約権（行使価額修正条項付）の大量行使に関するお知らせ

ハピネス＆Ｄ (31740)

Other 20251218 15:40

Company: Happiness & D Co., Ltd. (31740)
Event: Large-scale exercise of 13th new share subscription rights issued by third-party allotment
Exercise Period: December 1, 2025 to December 18, 2025
Exercised Rights: 1,500 out of 6,000 (25.0%) issued new share subscription rights
Issued and Remaining Rights:
Issued: 4,500 (450,000 shares)
Remaining: 3,000 (300,000 shares)

連結子会社の異動に関するお知らせ

ケア２１ (23730)

Other 20251218 15:30

Carey21 (23730) announces sale of all shares in its subsidiary NeuroNetwork on 2025-08-08.
As a result, Carey21’s stake in joint venture NeuCareNet falls below 50%, making it no longer a consolidated subsidiary.
NeuCareNet is a consulting firm for pharmacies with a capital of ¥20 million and was established in 2015.

資金の借入（金利決定）に関するお知らせ

Ｒ－オリックスＦ (89540)

Other 20251218 15:30

R-Orix F (89540) announces interest rates for loans mentioned in its previous notice on Dec 15, 2025.
Loan of ¥2.0 billion at 2.333% fixed rate from Mizuho Bank, due Jun 20, 2033.
Loan of ¥2.5 billion at 2.037% fixed rate from Norinchukin Bank, due Dec 20, 2034.
Unsecured loan of ¥2.5 billion at 2.148% fixed rate from Norinchukin Bank, due Dec 20, 2035.
Payment dates are business days; if not, the next business day is used, with adjustments for month-end situations.

役員の担当変更のお知らせ

長谷川香 (49580)

Other 20251218 15:30

Director role changed from Executive Officer, in charge of Sales & Marketing and Business Planning divisions, to Director.
New role is Director and continues as Executive Officer, overseeing the Research Institute, Sales & Marketing, and Business Planning departments.
Keeps position as Deputy Head of the Research Institute.
Announcement date: 2025-12-18
Effective date: 2025-12-18

人事異動に関するお知らせ

シークス (76130)

Other 20251218 15:30

New Outside Directors Appointed:
Kenji Futagoishi (formerly of Seven Bank)
Kiyoshi Handa (formerly of PFU)
Tetsu Ozaki (School Law Corporation President)
Retiring Outside Directors:
Naohiro Yoshizawa
Yasukoko Fuji
Role Changes for Existing Board Members:
Kazuyuki Hiragoka (CEO & COO to CEO & President)
Tomoaki Maruyama (COO to CFO)

監査等委員会設置会社への移行に関するお知らせ

ＪＩＡ (71720)

Other 20251218 15:30

JIA (7172) to transition from “Audit Committee Company” to “Monitoring Board Company”
Transition goal: Enhance corporate governance, improve long-term value and sustainability
Transition timeline: Subject to shareholder approval at the 20th Annual General Meeting in March 2026
Details of changes to be disclosed later; inquiries can be directed to IR department

事業計画及び成長可能性に関する説明資料

Ｇ－ＣＳ－Ｃ (92580)

Other 20251218 15:30

Local Business: 86%, Real Stores: 9%, Others: 5%
FY 2025/9 Sales ¥3.178B, Net Income ¥102M
Initiatives: Stock acquisition (Preedia), BPaaS services, new business hotel service, clinic business formalization
Japan Food Guide: 300 Omakase sushi shops, company collaborations
Real Store Business: 9 stores, domestic & international expansion plan by Sep. 2026

保有資産におけるプロパティ・マネジメント会社変更及びマスターリース会社選任に関するお知らせ

Ｒ－エクセレント (89870)

Other 20251218 15:30

Property Management Change: The current property management (PM) company for the Mansard Kodama facility will be changed.
New Master Lease and Property Management Company: A new master lease (ML) company and PM company has been selected - East Japan Community Co., Ltd.
Change Effective Date: The change will take effect on February 1, 2026.
Reason for Change: The new company was chosen due to its extensive knowledge of the surrounding area and a rich history of managing REITs and funds in ML and PM roles.
No Immediate Impact on Performance: No changes are expected in Excellent Realty Investment Trust’s operations or financial performance for the 2025 fiscal year (ending December 31, 2025) and the first half of 2026.

借入金の期限前弁済に関するお知らせ

Ｒ－エクセレント (89870)

Other 20251218 15:30

Early Repayment of Loan: Japanese Excellent Investment Corporation (8987) decided to repay a loan early on December 18, 2025.
Details of Early Repayment:
Amount: ¥2.8 billion
Scheduled Date: December 30, 2025
Source of Funds: Proceeds from the sale of Seinen Building and existing cash
Loan Details: The loan is a variable-rate loan from Mizuho Bank with an initial principal amount of ¥8 billion.
Impact on Debt: After the early repayment, short-term debt will decrease by ¥2.8 billion to ¥5 billion, while total debt will decrease to ¥127.6 billion.
No Change in Risk Factors: There are no changes to the risk factors related to this transaction as disclosed in the 38th periodic securities report for the fiscal year ending June 2025.

国内不動産の譲渡に関するお知らせ（仙信ビル）

Ｒ－エクセレント (89870)

Other 20251218 15:30

Summary:
Property Details:
Name:仙台インターシティ
Type:Office Building
Location:Sendai, Miyagi Prefecture, Japan
Gross Floor Area:17,250 sqm (approximately 185,687 sq ft)
Number of Floors:20 above ground, 3 below ground
Parking Lots:496
Year Built:2025
Investment Details:
Purchase Price:¥17,250,000,000 (approximately $138.3 million)
Investment Ratio:6.0%
Acquisition Date:April 15, 2025
Lease Rate:94.6% as of October 31, 2025
Portfolio Summary (as of January 31, 2026):
Total Investment Amount:¥285,941,000,000 (approximately $2.2 billion)
Number of Properties:47
Geographical Distribution:
Tokyo Metropolis and Surroundings: 37 properties (65.9%)
Osaka City Center Area: 2 properties (3.8%)
Nagoya City Center Area: 1 property (1.0%)
Fukuoka City Center Area: 1 property (1.7%)
Other Areas (including Sapporo, Sendai, and Hiroshima): 6 properties (11.9%)
Website:https://www.excellent-reit.co.jp/

第14回新株予約権（行使価額修正条項付）の下限行使価額の修正に関するお知らせ

Ｇ－フルッタフルッタ (25860)

Other 20251218 15:30

Company announces modification of minimum exercise price for 14th series of Warrants (with modification clause)
Current exercise price is ¥38, to be adjusted on specific dates based on company stock’s closing price
New minimum exercise price set at ¥62, applicable if closing price falls below it on adjustment dates
Company aims to maximize fundraising and maintain flexibility in warrant exercise prices
Warrants issued for potential expansion of Amazon Fruits business

執行役員の人事異動等に関するお知らせ

エラン (60990)

Other 20251218 15:30

CEO: Hinozaki Yuuhiko (previously CEO, now also CSO)
CSO: Ishizuka Akira (newly appointed, previously Executive Officer & Head of Strategy Division)
New President’s Office Chief: Ogura Hiroshi (new role, previously Executive Officer & CSO)
President’s Office Director: Kanno Yusuke (promoted from Executive Officer)
Internal Audit Division Director: Wakabayashi Ryo (reassigned from Operations Management Division Director)
Operations Management Division Director: Okazaki Hiroyuki (promoted from CMO)

借入金の期限前弁済に関するお知らせ

Ｒ－三菱地所物流 (34810)

Other 20251218 15:30

Early Repayment Decision: Mitsubishi Estate Logistics REIT (34810) will early repay a loan of ¥370 million on December 22, 2025.
Loan Details: The loan is a short-term (under 1 year), variable interest loan from Mizuho Bank with no collateral.
Impact on Debt Profile: After the early repayment, total debt will increase by ¥370 million to ¥117.849 billion, while long-term debt remains unchanged at ¥114.249 billion.
No Changes in Forecasts: This early repayment is already factored into the REIT’s Q2 2026 (Q19) operational outlook, so no changes are expected.
Risk Assessment Unchanged: There have been no changes in risk assessments related to this early repayment since the last securities report on November 27, 2025.

非上場の親会社等の決算に関するお知らせ

アビックス (78360)

Other 20251218 15:30

Abix Inc. (7836) announced the finalized consolidated financial results for its non-listed parent company, Terasu Holdings.
As of September 30, 2025, Terasu Holdings had total assets of ¥4,004.9 billion and total liabilities and net assets of ¥4,004.9 billion.
The company’s revenue for the nine months ended September 30, 2025, was ¥132.0 billion, with operating income of ¥186.6 billion and net income of ¥135.9 billion.
Abix Inc.’s holding in Terasu Holdings is 35.31% as of September 30, 2025.
The largest shareholder of Terasu Holdings is Orasion Co., Ltd., with a 73.7% stake.

株主優待制度の一部変更に関するお知らせ

フジ日本 (21140)

Other 20251218 15:30

Purpose of Change: To express gratitude to shareholders and enhance investment appeal.
Effective Date: January 1, 2026.
Key Changes:
Lowered stock thresholds for benefits.
Changed rewards from company products to QUO cards or increased product value.

ストック・オプション（新株予約権）の発行に関するお知らせ

Ｇ－セーフィー (43750)

Other 20251218 15:30

Initial NSSRs: 18,000,000; Additional NSSRs: 6,000,000.
Subscription price: ¥27,945 per NSSR.
Subscription periods: First period until end of following month; Second period June 1, 2026 to January 4, 2036.
No material changes in Chunk 2.
Total options issued: 4,000; Exercise price: ¥7,000 per option; Expiration date: December 31, 2028.

当社株式の上場廃止に関するお知らせ

ダイセキＳ (17120)

Other 20251218 15:30

Delisting Announcement: Dai-Seiki S stocks to be delisted on Dec 19, 2025.
Reason for Delisting: Special controlling shareholder Dai-Seiki requested and was approved for the sale of Dai-Seiki S ordinary shares.
Effective Date: Nov 28, 2025 board meeting where decision to approve the request was made.
Source of Details: Previous announcement dated Nov 28, 2025.
Gratitude Expressed: Thanks to shareholders and stakeholders for their support throughout the company’s history.

「しゅふJOB」システムの刷新開発に関するお知らせ

Ｇ－ビースタイルＨＤ (302A0)

Other 20251218 15:30

Purpose: Refresh “shufu JOB” system to maintain existing functionality, reduce operational costs by 60%, and increase revenue through new features.
New System Details:
Develop a successor system for the current “shufu JOB” using updated technology.
Add new features: direct recruiting, improved recommendation engine, shortened lead time, AI-supported resume creation, and reduced job posting costs.
Development Schedule: Two phases over two years (2026 & 2027) with internal project team and SI company technical support.
Estimated Cost: Approximately ¥600 million in total (¥130 million for phase 1, ¥470 million for phase 2).
Implementation Timeline: Decision made on Dec 18, 2025; planned use beginning in Jan 2028.
Financial Impact: No significant impact on the company’s Q3 2026 earnings forecast.

2025年11月度月次経営パラメータに関するお知らせ

アニコム　ＨＤ (87150)

Other 20251218 15:30

Net premium income for insurance policies in 2025 was around 5,300 million yen per month.
Number of active contracts increased from 1.297 million to 1.367 million between April and November 2025.
Average retention rate remained stable at approximately 88% throughout the period.
“Dobutsu Kenkō” (pet health) service applications fluctuated monthly but showed an upward trend, with a high of 24,388 applications in November 2025.
The company held 25 patents as of November 2025.

2025年度事業戦略説明会資料公開のお知らせ

東芝テック (65880)

Other 20251218 15:30

EKC Transformation:
Vision: Become leading global tech company in imaging & info systems.
Initiatives: Growth platforms (high-growth markets, new market expansion), operational excellence (efficiency, shared services), cultural transformation (innovation, talent retention).
Portfolio optimization: Divest non-core businesses, explore partnerships/joint ventures.
Toshiba Tec Business Strategies:
Retail business expansion: Increase sales, expand digital solutions, grow MPS.
Workplace solutions strengthening: Maintain printing market share, enhance competitiveness via ETRIA JV, expand office solutions.
Target CAGR of 10% in office solutions sales (FY2020-FY2024), increase recurring revenue.
RFID Technology Launch:
Launched RFID tag writing technology.
Collaboration with Toshiba Corporation for launch.
Wide range of applications covered.
FY2026 Revenue & Income Guidance:
Revenue: ¥4.5 trillion - ¥4.7 trillion
Operating income: ¥350 billion - ¥380 billion
Mid-term goal (FY2025-FY2027): 10% operating margin.
Capital expenditure in FY2026: Around ¥140 billion, primarily R&D & production facilities.

当社株式の上場廃止に関するお知らせ

三住建設 (18210)

Other 20251218 15:30

Stock Delisting: Sumitomo Mitsui Construction (18210) stocks will be delisted from Tokyo Stock Exchange’s Prime Market on December 19, 2025.
Shareholder Approval: Shareholders approved the proposal for a stock consolidation at an extraordinary general meeting held on November 18, 2025.
Reason for Delisting: The consolidation meets the delisting criteria set by Tokyo Stock Exchange’s listing rules.
Details: Further information can be found in Sumitomo Mitsui Construction’s press release dated November 18, 2025.
Gratitude and Future Commitment: The company expresses deep gratitude for shareholders’ understanding and support over the years and commits to enhancing corporate value and contributing to society.

投資事業有限責任組合（子会社）の設立に関するお知らせ

ＢＩＰＲＯＧＹ (80560)

Other 20251218 15:30

BIPROGY established BCF1 investment limited liability partnership on Dec 18, 2025.
BCF1 aims to grow startups into global problem-solving companies.
Initial investment of up to 50 billion yen, with BIPROGY contributing up to 49.5 billion.
Targeting seed and early-stage startup companies in Japan and BIPROGY’s core/growth business areas.
BCF1 to be established on Jan 14, 2026 (pending contract signing on Dec 19, 2025).

新経営体制に関するお知らせ

Ｇ－サイバー・バズ (70690)

Other 20251218 15:30

New Management Structure Approved: The company’s 20th ordinary general shareholders’ meeting approved the election of directors as proposed.
Board of Directors Decided:
Representative Director and CEO: Takao Takamori (高村彰典)
Directors: Masahiro Iwakami (岩田真一), Yuta Mikami (三木佑太), Yasushi Futaba (膽畑匡志)
Newly Appointed Auditors:
External Directors: Akiyo Asagi (都賢治), Makoto Matsumoto (松本浩介)

当社主要ＫＰＩ（2025年11月度）に関するお知らせ

Ｇ－プロディライト (55800)

Other 20251218 15:30

G-ProDilight (55800) announces major KPIs for November 2025.
Discloses INNOVERA PBX account numbers and IP-Line channel numbers.
Past 12 months’ progress will be publicly available monthly.
Figures are accurate as of the disclosure date.

当社株式の上場廃止に関するお知らせ

ＴＡＣ (43190)

Other 20251218 15:30

TAC’s (43190) ordinary shares delisted from Tokyo Stock Exchange Standard Market on Dec 19, 2025.
Delisting follows share consolidation approved at TAC’s extraordinary general meeting held on Dec 1, 2025.
TAC thanks shareholders and stakeholders for their support since its IPO in 2001.
Company aims to enhance corporate value and continues to seek understanding and support from shareholders.

カンパニー制導入に関するお知らせ

Ｇ－ＪＲＣ (62240)

Other 20251218 15:30

Background: JRC Group expanded its business areas from conveyor systems to environmental plant and robot SI businesses, with increased group companies through M&A.
Rationale for Company System Introduction: To clarify responsibilities and speed up decision-making for sustainable growth.
Company System (カンパニー制): An operating structure that treats each business as an independent management unit with clear authority and responsibility.
Objectives: Enhance strategic clarity, increase autonomy and agility, create synergies, strengthen profitability and efficiency, develop next-generation leaders.
Implementation Timeline: New organizational structure to begin operation on March 1, 2026.

取締役の役職変更に関するお知らせ

ＣＥＨＤ (43200)

Other 20251218 15:30

Board Changes Approved: The 30th ordinary general shareholders’ meeting approved the appointment of directors as proposed.
Role Clarification: After the meeting, the board decided to change roles for clearer responsibilities in management.
New Roles Announced:
Hagi Eichi: CSO (Chief Strategy Officer), previously COO
Taguchi Tsunehito: CFO (Chief Financial Officer), no change
Fujimoto Kaori: CHRO (Chief Human Resources Officer), new role

配当金の受領に伴う売上高の計上見込みに関するお知らせ

プロレドパートナーズ (70340)

Other 20251218 15:30

Expected Revenue Increase: Proledopartners (7034) expects to record JPY 700 million in revenue for the first quarter of FY2026 due to receipt of dividends from investee companies.
Nature of Revenue: The recorded revenue will be from dividends received, not from direct sales or services.
Impact on Annual Results: The effect of this increased revenue on Proledopartners’ full-year consolidated performance is still under review, considering other factors.
Non-controlling Interest Adjustment: A portion of the recorded revenue (representing non-controlling interests) will be subtracted from consolidated net income.

子会社への会社分割（簡易吸収分割）に関するお知らせ

ゼロ (90280)

Other 20251218 15:30

Zero Corporation (90280) announces a simple absorption-type division to its wholly-owned subsidiary, Zero Plus Maintenance Corporation.
The division involves transferring certain rights and obligations of large-scale maintenance and new vehicle delivery pre-maintenance businesses to Zero Plus Maintenance Corporation.
This move aims to improve operational efficiency, optimize the business portfolio, and clarify management responsibility within the Zero Group.
The division is expected to occur on July 1, 2026, with no change in capital or shares issued.

株式会社2WINSとのAIソリューション開発基本契約締結のお知らせ

Ｇ－ＡｐｐＢａｎｋ (61770)

Other 20251218 15:00

Contract signed with 2WINS for AI Solution Development
Purpose: Expand AI solution business as per approved new management structure.
Details: Contract period from Dec 2025 to Oct 2026, total development cost of ¥60,000,000 planned.
Contract Party: 2WINS (est. Feb 2022), primarily engaged in AI solutions, with no capital or personal ties to the company.
No material changes stated regarding related parties or financial status.

連結子会社からの配当金受領に関するお知らせ

Ｇ－ＳＡＡＦＨＤ (14470)

Other 20251218 15:00

Dividend received: ¥97 million from subsidiary Incneed on November 28, 2025.
Impact on individual results: To be recognized as extraordinary income in the Q3 FY2026 individual financial statements.
No effect on consolidated results: As it’s a dividend from a subsidiary, no impact on the group’s FY2026 Q3 results.

財務上の特約が付された金銭消費貸借契約締結に関するお知らせ

レオクラン (76810)

Other 20251218 15:00

Leo Crane (7681) announced signing a loan agreement with financial covenants.
The purpose is to replace an existing bridge loan taken for Fascia Holdings’ shares purchase.
Loan details: ¥50 billion from MUFG Bank, 10-year term, unsecured but guaranteed by Fascia Holdings and Form Corporation.
Covenant: No two consecutive years of negative operating profit in consolidated and standalone P&L.
The impact on FY2026 group results is expected to be minor.

連結総資産の増加に関するお知らせ

豊トラスティ証券 (87470)

Other 20251218 15:00

Date of Increase: December 18, 2025
Reason for Increase: Increase in collateral (margin) received from a specific client for commodity derivatives business during the third quarter of FY2026 (October 1, 2025 to December 31, 2025)
Amount of Increase: ¥6.32 billion increase in both consolidated total assets and consolidated total liabilities
Nature of Collateral: Temporary, aimed at avoiding market risk
Impact on Future Financial Results: Minimal impact on the consolidated financial results for FY2026

本店移転に関するお知らせ

エイジス (46590)

Other 20251218 15:00

Headquarters Relocation Announced
New Location: Chiba, Japan (Chiba City, Wakaba Ward)
Relocation Date: December 26, 2025
Reason for Relocation: Sale of current headquarters due to building deterioration and resource optimization
Impact on Performance: No change expected in fiscal 2026 Q3 results

連結子会社（孫会社）の異動に関するお知らせ

石油資源 (16620)

Other 20251218 14:00

JAPEX (石油資源開発株式会社) acquires full ownership of Verdad Resources Intermediate Holdings LLC (VRIH) in the US.
Acquisition is done through Peoria Resources, LLC (Peoria), a wholly-owned subsidiary of JAPEX’s foreign consolidated subsidiary.
The acquisition will not impact JAPEX’s consolidated financials for the fiscal year ending March 31, 2026.

Verdad Resources Intermediate Holdings LLCの全持分取得による米国タイトオイル・ガス資産の取得および連結子会社（孫会社）の異動に関するお知らせ

石油資源 (16620)

Other 20251218 14:00

JAPEX acquired full ownership of Verdad Resources Intermediate Holdings LLC (VRIH) via Peoria Resources Acquisition Company, LLC.
The acquisition includes tight oil and gas assets in Colorado and Wyoming, with current production of approximately 35,000 boed (net), expected to increase to around 50,000 boed by 2030.
JAPEX plans to operate these assets through Peoria Resources, LLC as a strategic move to expand its US E&P business and ensure profitability.
The acquisition cost is approximately $1.3 billion, to be funded by both JAPEX’s own capital and borrowings.

株主優待制度の拡充に関するお知らせ

Ｇ－ＴＫＰ (34790)

Other 20251218 14:00

Purpose of Change: To enhance the shareholder benefits program based on shareholder feedback to increase the attractiveness of TKP’s stock investment.
Expansion Details: Adding two new facilities (Restaurant Takka and TKP Restautant Takka Rooftop Bar at APA Hotel in Oita) to the existing 20, making it a total of 22 shareholder benefit facilities.
Application Start Date: December 3, 2025.
Shareholders Eligible: Those listed on TKP’s shareholder registry as of February 28, 2025.

（開示事項の経過）アラブ首長国連邦における販売会社設立完了に関するお知らせ

やまびこ (62500)

Other 20251218 14:00

Yamabiko (62500) established a sales subsidiary in the United Arab Emirates.
Subsidiary’s name: YAMABIKO GENERAL TRADING FZE, located in Jebel Ali Freezone Authority, Dubai.
Subsidiary’s purpose: Sale of compact outdoor work machines and general industrial machinery in the Middle East region.
Yamabiko will supply products/parts to the subsidiary and has appointed an executive to lead it.
Subsidiary aims to start operations in March 2026.

株主優待制度の運用に関するお知らせ

クリヤマＨＤ (33550)

Other 20251218 13:30

Revival of Shareholder Benefit Scheme: CRIYAMAHOLDINGS (3355) revives its shareholder benefit scheme to express gratitude and boost long-term investment in its shares.
Eligibility Requirements:
Must be on the company’s shareholder register as of December 31 each year.
Must have continuously held at least 200 ordinary shares for over a year.
Benefits: Rewards vary based on the number of shares held and the duration of continuous holding, offering credits ranging from ¥1,000 to ¥8,000 on Quo Card.

株主優待一部変更（デジタルギフトメニューの追加）に関するお知らせ

シンシア (77820)

Other 20251218 13:00

Shareholder Benefit Change: Added “Amazon Gift Card” to the list of available digital gifts.
Eligible Shareholders: Remain those who own 200 or more shares for at least one year, or 300 or more shares for at least three years as of December 31, 2025.
Selection Method: “Shareholder Benefit Notification” will be sent to eligible shareholders. Choose preferred gift online within the specified period.
Additional Benefits: Special discount coupons for official website purchases remain unchanged from previous announcements.
Effective Date: Changes apply to shareholders listed in the December 2025 shareholder registry.

第三者割当による第９回新株予約権の発行に係る、資金調達の使途変更に関するお知らせ

ｆａｎｔａｓｉｓｔａ (17830)

Other 20251218 12:30

Change in Funds Allocation: Fantasia Inc. (TSE: 1783) has decided to add gold acquisition to the funds raised from the 9th issue of new shares.
Reason for Change: The company aims to further enhance its mainstay real estate business with additional pillars like battery storage and hotel businesses, and diversify its asset portfolio by acquiring cryptocurrencies and gold.
Funds Reallocation Details: Out of the expected funds (¥91.8 billion), ¥4.215 billion intended for cryptocurrency acquisition will now partly be used to acquire gold.
Expected Impact: This change is expected to reduce long-term price volatility risk and improve overall financial stability, while maintaining short-term business flexibility. It does not currently impact the company’s forecasted performance.

収益不動産の取得に関するお知らせ

ディア・ライフ (32450)

Other 20251218 12:30

Acquisition Announcement: Diar Life (32450) acquired a yield-generating property.
Property Details: Located near “Yotenji” Station on the Tokyu Toyoko Line, with excellent access to major city terminals and surrounded by nature, history, cultural sites, parks, and convenient living facilities.
Property Summary:
Name: DeLCCS YotenjiⅡ
Location: Meguro-ku, Ebara 2-chome
Access: 4-min walk from “Yotenji” Station on the Tokyu Toyoko Line
Floor Area: 894.63 sqm (270.62 tsubo)
Structure/Scale: Reinforced concrete with a flat roof, 1 basement level + 3 floors above ground
Usage: Apartment building and bicycle parking
Acquisition Funding: Self-funded and bank loans.
No Material Changes to Future Forecasts: The acquisition will have a negligible impact on the consolidated earnings for the current fiscal year (ending Sep. 2026).

取締役及び執行役員の異動に関するお知らせ

Ｇ－シャノン (39760)

Other 20251218 12:00

New Role for Takashi Yamazaki: Represented as “Kaitaku Yaku CEO” (President and CEO)
New Executive Appointments:
Atsushi Kataoka to Executive Officer, Solutions Sales
Masahiko Nakai to Executive Officer, Event Cloud Business
Role Changes:
Hiroshi Kondo from Marketing Cloud Business to COO
Akira Asano from CMO and SMB to Executive Officer, CMO
Takashi Matsuo from Executive Officer to Director and Executive Officer
No Changes for:
CTO: Hisao Inoue
Product Strategy: Mitsugu Hori
CFO: Manabu Tomonaga
Event Solutions Service: Satoshi Nakata

TI霧島太陽光発電所の電柱移設工事完了のお知らせ

Ｉ－東京インフラＦ (92850)

Other 20251218 10:00

Pole Relocation Completed: The electric pole relocation work at TI Kirishima Solar Power Plant has been completed.
Date of Completion: December 15, 2025
Inspection Completed: On-site confirmation by the management company staff was finished on December 16, 2025.
Minimal Impact on Operations: The cost related to this relocation is covered by insurance and will have a negligible impact on the 2025 December period (Q16) operation projections.
Previous Announcements: This follows an earlier announcement about potential risks due to heavy rainfall and Typhoon 12 in August 2025.

抗体-薬物複合体PADCEV（エンホルツマブ　ベドチン）シスプラチン適応の筋層浸潤性膀胱がんを対象とした第III相EV-304試験において良好な結果が判明

アステラス薬 (45030)

Other 20251218 08:30

PADCEV (Enfortumab Vedotin) + Pembrolizumab showed promising results in Phase III trial EV-304 for cisplatin-eligible muscle-invasive bladder cancer.
Trial compared neoadjuvant chemotherapy, measured EFS, OS, and pCR rate. PADCEV targets NECTIN-4 protein.
Phase III EV-304 trial positive: PADCEV improved OS & PFS vs. chemo in locally advanced/metastatic urothelial carcinoma.
Improvement consistent across subgroups, safety profile aligned with previous reports.

東京証券取引所グロース市場への上場に伴う当社決算情報等のお知らせ

Ｇ－ミラティブ (472A0)

Other 20251218 08:00

Business Profile: Single-segment (Mirativ Platform), main revenue: course sales & advertising
2025 Year-End Forecasts:
Total Revenue: ¥7,004 million (14.9% increase YoY)
Course Sales: ¥6,586 million (13.4% increase YoY)
Advertising Sales: ¥297 million (2.8% increase YoY)
EBITDA: ¥229 million (turnaround from ¥-245 million loss)
Net Income: ¥593 million (turnaround from ¥-259 million loss)
3Q 2025 Results:
Revenue: ¥5,211.686 million
Operating Profit (EBITDA): ¥276.462 million
Net Income: ¥231.351 million
Listing Transition: Moved to TSE Growth Market on Dec 24, 2025

事業計画及び成長可能性に関する事項

Ｇ－ミラティブ (472A0)

Other 20251218 08:00

Live game streaming platform Mirrativ connects users based on shared interests.
Users can gift each other digital contents like 3D avatars, generating revenue for the company.
Mirrativ’s business model includes coin purchases, ads, and in-app content sales.
The platform aims to foster long-term engagement and support individual user narratives.
Mirrativ introduced “Gift Gacha” feature and collaborated with streamers for in-game events.

Corporate & Strategic Updates

MN-166（イブジラスト）の化学療法誘発性末梢神経障害を対象とするフェーズ2b臨床試験（OXTOXスタディ）の患者登録完了に関するお知らせ

メディシノバ (48750)

Corporate & Strategic Updates 20251218 20:00

Patient enrollment completed for Phase 2b clinical trial (OXTOX Study) of MN-166 (Ibetzolast) to prevent/mitigate chemotherapy-induced peripheral neuropathy in metastatic colorectal cancer patients.
Study design: Multi-site, placebo-controlled, randomized, double-blind, with 100 patients enrolled across 11 facilities in Australia.
Trial drug: Patients receive either MN-166 (Ibetzolast) at 60mg/day or placebo alongside oxaliplatin chemotherapy.
Primary endpoint: To evaluate the effect of MN-166 on reducing acute neurotoxicity symptoms and CIPN induced by oxaliplatin.
Expected completion: End of 2026, with top-line data to be announced in late 2026.

当社連結子会社による株式会社サン・スマイルの全株式の取得（連結子会社化）及び財務上の特約が付された金銭消費貸借契約の締結に関するお知らせ

Ｇ－ＡｎｙＭｉｎｄ (50270)

Corporate & Strategic Updates 20251218 17:30

Acquisition of Sunao Co., Ltd. by Subsidiary
Target: Sunao Co., Ltd. (Beauty & Health business)
Purchase Price: ¥37.5 billion ($329 million USD)
Funding and Financing
Source: Cash on hand and new debt financing
Expected Impact and Strategy Alignment
Significant contribution to consolidated earnings from fiscal 2023
Aligns with company’s medium-term growth strategy for business domain expansion
Acquisition of San-Smile Inc. by Subsidiary
Target: San-Smile Inc.
Purchase Price: ¥4,099 million (approx. USD 32.5 million)
Funding: Loan agreement with financial covenants

（訂正）「2025年度　第２四半期　決算概要」の一部訂正について

ＯＫＩ (67030)

Corporate & Strategic Updates 20251218 17:00

Correction Announced: OKI Electric Industry, Ltd. (6703.T) corrects its 2025 Q2 financial highlights.
Reason for Correction: Errors found in the segment-wise overview of Enterprise Solutions.
Corrections Available: Details provided in a separate sheet, with corrections marked in red boxes.
Contact Information: IR Room Long Bridge, Phone: 03-5635-8212.

（訂正）「2024年度　決算概要」の一部訂正について

ＯＫＩ (67030)

Corporate & Strategic Updates 20251218 17:00

OKI (67030) corrects part of its “Fiscal Year 2024 Earnings Overview” announced on May 8, 2025.
Correction is due to errors in the progress of the Medium-Term Management Plan 2025 and its management targets (page 13).
Detailed correction details are provided in an attached sheet, with corrected sections highlighted in red boxes.

簡易株式交換による株式会社マナスコーポレートパートナーズの完全子会社化に関するお知らせ

山田コンサル (47920)

Corporate & Strategic Updates 20251218 16:00

Purpose of the simplified share exchange: Mountain Consulting Group (47920) aims to strengthen its M&A advisory services in India and expand its global network by acquiring a majority stake in Manas Corporate Partners.
Share exchange details:
Exchange ratio: 153.548 Mountain Consulting Group shares for 1 Manas share
Shares issued: 76,774 new Mountain Consulting Group ordinary shares
Timeline of the simplified share exchange: Agreement signed on Dec 18, 2025; Manas shareholders’ approval on Jan 15, 2026 (expected); effective date on Jan 19, 2026 (expected).
Minor impact expected on Mountain Consulting Group’s consolidated financial results post the share exchange.

連結子会社による孫会社の吸収合併に関するお知らせ

ウイン・パートナーズ (31830)

Corporate & Strategic Updates 20251218 15:30

Company: ウイン・パートナーズ (31830)
Date: December 18, 2025
Subsidiary: TESCO Corporation to absorb MS-I Inc.
Purpose: To enhance group synergies and integration of operations

株式の取得（完全子会社化）に関するお知らせ

オンワードＨＤ (80160)

Corporate & Strategic Updates 20251218 15:30

Onward HD to acquire all shares of Cosme De Bote, making it a wholly-owned subsidiary.
Acquisition aligns with Onward HD’s long-term business strategy focused on the “Wellness Domain”.
No significant changes in capital relationship, personal relationship, or business transactions between Onward HD and Cosme De Bote.
Onward HD will own 100% of Cosme De Bote after acquisition (1,800 shares).
Acquisition cost is approximately ¥36 billion, excluding target company’s net cash.

子会社の吸収合併（簡易合併・略式合併）及び債権放棄に関するお知らせ

ＢＩＰＲＯＧＹ (80560)

Corporate & Strategic Updates 20251218 15:30

BIPROGY (80560) to absorb its wholly-owned subsidiary Emellience Partners on April 1, 2026.
The absorption is a simple merger for BIPROGY and a short-form merger for Emellience Partners.
BIPROGY will forgive ¥1.5 billion of debt owed by Emellience Partners before the merger.
No new shares or other compensation will be issued in this 100% subsidiary absorption.
The merger will not affect BIPROGY’s consolidated financial results.

連結子会社間の吸収合併並びに連結子会社の商号変更に関するお知らせ

Ｇ－ＪＲＣ (62240)

Corporate & Strategic Updates 20251218 15:30

Purpose of Merger and Name Change: To strengthen Group’s response to increasing maintenance needs in environment and power plants, merge knowledge from both fields, and improve one-stop solutions for clients.
New Company Name: “JRC E&E” (JRC Environment & Energy) to symbolize unity under JRC Group brand and enhance customer recognition and trust.
Merger Details:
Merger effective date: March 1, 2026 (tentative)
Method: Absorption-type merger; High Bridge Industrial Furnace remains as the surviving company.
No stock or other assets allocated for this merger.
Post-Merger Company Overview: JRC E&E will be based in Kawasaki with capital of ¥10,000,000 and 100% owned by JRC.

連結子会社の吸収合併（簡易・略式合併）に関するお知らせ

アマダ (61130)

Corporate & Strategic Updates 20251218 15:30

Acquisition of Two Subsidiaries: Amada (6113.T) has resolved to absorb and consolidate its 100% subsidiaries, Amada Hokkaido and Amada Business Support.
Effective Date: The acquisition is scheduled for April 1, 2026.
Type of Acquisition: This is a simplified (for Amada) and abbreviated (for the subsidiaries) merger under Japanese law, requiring no shareholder meeting approval.
No Capital Changes: Since it’s an absorption of 100% subsidiaries, there will be no new shares issued or cash distributed.

三菱商事ライフサイエンス株式会社との共同研究開発に伴う化粧品原料候補「抗好中球エラスターゼアプタマー」のPCT出願完了のお知らせ

Ｇ－リボミック (45910)

Corporate & Strategic Updates 20251218 15:30

Ribomic completed PCT patent filing for “ant Neutrophil Elastase aptamer” cosmetic ingredient candidate with Mitsubishi Corporation Life Sciences.
Initial domestic patent application for the same was filed on January 7, 2025.
This move aims to protect and expand business globally.
No impact expected on FY2026 Q3 earnings.

株式会社京榮建設不動産の株式の取得（子会社化）完了に関するお知らせ

Ｐ－ゼロジャパン (171A0)

Corporate & Strategic Updates 20251218 15:00

P-Zero Japan (171A0) completed acquisition of all shares in Keisei Kogyo Fudousan, making it a wholly-owned subsidiary.
Keisei Kogyo Fudousan is engaged in renovation/repair contracting and real estate leasing, with a capital stock of 100 million yen.
The acquisition was finalized on December 18, 2025, with P-Zero Japan obtaining 139,387 shares (100% ownership).
The acquisition will result in a negative goodwill adjustment in P-Zero Japan’s FY2026 earnings, to be recorded as extraordinary income.
P-Zero Japan will promptly disclose any further relevant information that arises.

連結子会社間の合併に関するお知らせ

Ｐ－バレッグス (239A0)

Corporate & Strategic Updates 20251218 15:00

Purpose of Merger: To consolidate and optimize resources, improve operational efficiency within the Balleggs Group.
Merger Details: Absorption merger between P-Balleggs (239A0) subsidiaries: BalloDevelopment (surviving company) and BalloGarantee (dissolving).
Effective Date: February 1, 2026 (tentative)
No New Shares or Cash Payment: As it’s an intra-group merger between consolidated subsidiaries.
No Impact on Consolidated Earnings: The merger is expected to have a minimal effect on Balleggs’ connected financial statements.

Regulatory / Legal / Governance

臨時株主総会招集のための基準日設定に関するお知らせ

Ｇ－イメージ情 (38030)

Regulatory / Legal / Governance 20251218 18:00

Record Date: January 9, 2026 (Friday)
Notice Date: December 26, 2025 (Friday)
Notice Method: Electronic notice on company’s homepage (https://image-inf.co.jp/?page_id=55)
Meeting Date: Mid-March 2026

（開示事項の経過）第三者委員会の調査結果報告書に関する追加のお知らせ

Ａｂａｌａｎｃｅ (38560)

Regulatory / Legal / Governance 20251218 17:00

Investigation Results: The investigation by the third-party committee has been accepted seriously.
Prevention Measures: Preventive measures are being formulated and implemented based on their recommendations.
Further Actions: Detailed verification of individual cases will be conducted, with additional preventive measures to be determined and announced later.
Apology: Company apologizes for causing significant concern and inconvenience to shareholders, investors, and other stakeholders.

定時株主総会議案の一部撤回に関するお知らせ

Ｇ－Ｗａｑｏｏ (49370)

Regulatory / Legal / Governance 20251218 15:30

Withdrawn Item: “定款一部変更の件” - Change to allow for location-less shareholders’ meetings
Reason for Withdrawal: Inadequate prior process review led to re-evaluation of the proposal
Updated Proposal:
Reason: Enhance medical support business and prepare for future expansion into used medical equipment sales
Changes: Add “16. Sale, import/export, and management of antiques” to company’s purpose clause

株式併合並びに単元株式数の定めの廃止及び定款の一部変更に関する臨時株主総会開催のお知らせ

アイネット (96000)

Regulatory / Legal / Governance 20251218 13:00

Merger Approved: Company approved merger with another entity.
Share Capital Increase: Share capital increased to ¥56,429,783.
Unit Share System Abolished: Unit share system has been abolished following the merger approval.
New Shares Issued: New shares issued as merger consideration.
Election Results Announced: No change in the number of directors; election results announced.
Next General Meeting Scheduled: Next ordinary general meeting set for April 10, 2026.

当社子会社の(株)トランスジェニックにおけるGLP適合性調査の結果について

Ｇ－トランスＧＧ (23420)

Regulatory / Legal / Governance 20251218 12:00

Data Manipulation Incident: An employee manipulated data in HPLC and LC-MS/MS analyses at a drug development company, compromising study integrity and potentially impacting social trust and client confidence.
Root Causes and Corrective Actions: Lack of proper education on GLP and DI, insufficient monitoring and auditing, inadequate software controls, and poor data management practices led to the incident. Corrective actions included enhanced training, strengthened access controls, strict data management procedures, and updated SOPs.
Potential Concerns: While corrective actions address root causes, effectiveness of education may be difficult to measure, and some manipulations might still go undetected.
SOP Changes for Data Control: Implement Thermo LC-MS/MS data output forms, limit PDF outputs, use numbered printer paper, require two operators or a separate recorder for data deletion, log in/out times and operator names, limit file movement, and prevent unauthorized data manipulation.
GLP Compliance: Transgenic’s GLP compliance was confirmed with no significant issues found in the audit. Quality assurance program was validated, minor observations were noted with planned corrective actions, and there was no impact on Transgenic’s operations or G-TRANS’ business.

Financial Results & Forecasts

業績予想の修正に関するお知らせ

Ｐ－大友ロジスティク (91490)

Financial Results & Forecasts 20251218 17:00

Revised Forecast for FY 2025 (ending Oct. 31, 2025)
EPS: Revised from ¥28.40 to ¥28.14 (-¥0.9 or -0.9%)
Operating Profit: Revised from ¥470M to ¥999M (+¥528.298M or +112.3%)
Ordinary Income: Revised from ¥473M to ¥772M (+¥298.259M or +63.0%)
Net Income: Revised from ¥309M to ¥569M (+¥260.528M or +83.7%)
Reasons for Revision:
Decrease in sales due to reduced production of construction machinery
Increased personnel costs due to higher turnover rate and lower-than-expected fuel prices
Tax benefits from employment expansion tax incentives
Note on Forecast:
The company’s outlook is based on information currently available

業績予想の修正および特別損失（減損損失）計上見込みに関するお知らせ

Ｇ－カルナバイオ (45720)

Financial Results & Forecasts 20251218 17:00

Revenue expected to be ¥560 million, a decrease of 22.4% from the previously announced forecast.
Research and development expenses expected to be ¥1,896 million, a decrease of 7.9% from the previous forecast.
Special loss (impairment loss) of ¥25 million expected to be recognized due to decreased recoverability of assets in certain business segments.
Net loss attributable to parent company shareholders expected to be ¥2,223 million, an increase of ¥76 million from the previously announced forecast.
No material changes stated regarding operating income or losses.

次期業績予想および次期配当予想に関するお知らせ

ＣＹＢＯＺＵ (47760)

Financial Results & Forecasts 20251218 15:30

Fiscal Year 2026 Business Forecast (Consolidated):
Revenue: ¥42,168 million
Operating Profit: ¥10,514 million
Ordinary Income: ¥10,732 million
Net Income: ¥161.02 million
Fiscal Year 2026 Business Forecast (Individual):
Revenue: ¥40,562 million
Operating Profit: ¥12,249 million
Net Income: ¥7,550 million
Fiscal Year 2026 Dividend Forecast:
Annual Dividend: ¥50.00 (¥0.00 per quarter)
Previous Year’s Dividend: ¥40.00 (¥0.00 per quarter)

（訂正・数値データ訂正）「2025年12月期第３四半期決算短信〔日本基準〕(非連結)」の一部訂正について

Ｇ－ソフトＭＡＸ (36710)

Financial Results & Forecasts 20251218 15:30

Correction in Summary of Q3 Financial Results (Non-consolidated)
Affected areas:
Annual dividend payout for FY2024
EPS forecast for FY2025 (full year)
Changes made:
FY2024 annual dividend: 30.00 yen/share (previously 7.50 yen/share)
FY2025 EPS forecast: 20.02 yen/share (previously 80.08 yen/share)
Reason for correction: No impact on profits; correction made after initial announcement

（訂正・数値データ訂正）「2025年12月期第２四半期（中間期）決算短信〔日本基準〕(非連結)」の一部訂正について

Ｇ－ソフトＭＡＸ (36710)

Financial Results & Forecasts 20251218 15:30

Correction Details Announced: Corrections are being made to the Summary section of the “2025 Year End Second Half (Interim) Financial Results” report published on August 12, 2025.
Affected Items: The corrections involve two items:
2024 Year-end Annual Dividend Result
Per-share Full-year Forecast for Net Income
Correction Reason: The corrections are due to errors in the numerical presentation after the financial results were announced. These corrections will not affect the overall profit.
Corrected Figures:
2024 Year-end Annual Dividend Result: Corrected from 7.50 yen to 30.00 yen per share
Per-share Full-year Forecast for Net Income: Corrected from 80.08 yen to 20.02 yen

2026年２月期通期連結業績予想及び配当予想の修正に関するお知らせ

Ｇ－ＪＲＣ (62240)

Financial Results & Forecasts 20251218 15:30

Revenue forecast adjusted for 2026 Feb period: ¥13,450 million (previous: ¥13,663 million)
Profit forecasts increased due to higher margins in Conveyor business and improved case yield in Robot SI business:
Operating profit: ¥1,830 million (previous: ¥1,728 million)
Ordinary profit: ¥1,815 million (previous: ¥1,713 million)
Net income attributable to parent: ¥1,220 million (previous: ¥1,147 million)
Dividend forecast adjusted for fiscal year 2025: Annual dividend per share increased by ¥1 to ¥29

配当予想の修正（増配）に関するお知らせ

Ｇ－ソフトＭＡＸ (36710)

Financial Results & Forecasts 20251218 15:30

Dividend Forecast Increased: Company revised its dividend forecast for the year ending December 31, 2025.
New Dividend Amount: The new dividend per share is ¥10.00, an increase of ¥2.50 from the previously announced ¥7.50.
Previous Forecast: The previous forecast, announced on May 27, 2025, was for a ¥7.50 dividend per share.
Stock Split: The company conducted a 4-for-1 stock split on July 1, 2025, which affects the comparison of dividends per share across periods.
Disclaimer: Actual dividends may differ from the forecast due to various factors.

2026年２月期第３四半期決算速報値（連結）に関するお知らせ

ニューテック (67340)

Financial Results & Forecasts 20251218 15:30

Revenue: 4,029 million yen (up 27.3% YoY)
Operating Profit: 312 million yen (up 81.2% YoY)
Ordinary Profit: 304 million yen (up 77.3% YoY)
Net Income Attributable to Parent: 233 million yen (up 76.3% YoY)
Updated Financial Results Disclosure: Company published a revised forecast for full-year 2025 due to special loss accounting

特別損失の計上に伴う通期業績予想及び配当予想の修正（無配）に関するお知らせ

ニューテック (67340)

Financial Results & Forecasts 20251218 15:30

NTT (67340) will record a special loss in the 2026 February period.
The company is modifying its full-year consolidated earnings forecast and dividend forecast due to this special loss.
The acquisition of NTT shares by SXC (the acquirer) has been approved, and if successful, no dividends will be paid out at the end of the 2026 February period.
As a result of the takeover, advisory fees, legal fees, and other expenses totaling around ¥300 million will be recorded as a special loss in this period.
The company’s full-year consolidated earnings forecast for the 2026 February period has been revised down by approximately ¥190 million (¥41.7 million) due to these extraordinary costs.

剰余金の配当（中間配当・増配）及び期末配当予想の修正に関するお知らせ

アソインター (93400)

Financial Results & Forecasts 20251218 14:30

Dividend Increase: Asso International (93400) has decided to increase its interim and final dividends for the fiscal year ending June 2026.
Amount Increase: The interim dividend will be increased by 1 yen to 13 yen per share, and the final dividend is also set at 13 yen per share, making the total annual dividend 26 yen per share.
Base Earnings: This increase is based on a projected consolidated net income of 504 million yen for the fiscal year ending June 2026.
Effective Date: The dividends will be payable on March 31, 2026.